![Leila Jaafar-Thiel](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Leila Jaafar-Thiel founded Nuclidium AG in 2017, where she is working as Chief Executive Officer & Director from 2017.
Dr. Jaafar-Thiel also founded Swiss Nuclides AG, where she is working as Chief Executive Officer.
| Sociétés | Poste | Début |
|---|---|---|
Swiss Nuclides AG
 Swiss Nuclides AG Hospital/Nursing ManagementHealth Services Provides cancer patients diagnostics and radiopharmaceutical therapy treatment services | Directeur Général | - |
Nuclidium AG
 Nuclidium AG Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops radiopharmaceuticals for treatment of cancer | Fondateur | 01/01/2017 |
Actives
Inactives
Sociétés cotées
Entreprise privées
| Entreprise privées | 2 |
|---|---|
Swiss Nuclides AG
Swiss Nuclides AG Hospital/Nursing ManagementHealth Services Provides cancer patients diagnostics and radiopharmaceutical therapy treatment services | Health Services |
Nuclidium AG
Nuclidium AG Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops radiopharmaceuticals for treatment of cancer | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
